CClinicalTrials.gg
CompletedNCT02728141Updated Apr 5, 2016

Healthy Infant Development Project - Sucrose Component

An interventional study of Water and Sucrose in Iron Deficiency, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Completed at 1 site in China. Open to participants aged 1 Day to 5 Days. Per ClinicalTrials.gov, last updated 2016-04-05.

Sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
424
Allocation
Randomized
Ages
1 Day to 5 Days
Sex
All
01

Study summary

Iron deficiency affects the opioid and dopamine systems in rodent models, with a higher pain threshold. The opioid system is involved in sucrose's ability to reduce pain and distress during neonatal procedures. Thus, prenatal iron deficiency might affect response to pain and sucrose analgesia. In order to compare response to pain and sucrose during heel stick in neonates with and without iron deficiency, healthy full-term Chinese infants were randomized to receive sucrose or water by syringe beforehand, in conjunction with heel stick for metabolic screening.

02

Conditions studied

  • Iron Deficiency
03

In context

Anemia, Iron-Deficiency

644 studies on the registry are indexed under Anemia, Iron-Deficiency; 105 are open to participants now.

This study's enrollment of 424 is above the median of 100 across 503 interventional studies indexed under Anemia, Iron-Deficiency.

Browse Anemia, Iron-Deficiency studies →

Lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is the lead sponsor of 416 studies on the registry; 25 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 10 (77%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 5 Days
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Full term healthy neonates participating in the Healthy Infant Development RCT (NCT00613717) in the folic acid/early postnatal placebo group and pre- and early postnatal iron-supplemented infants.

Exclusion criteria

Exclusion Criteria:

  • birth weight \< 2500 g gestational age ≤ 37 wk major perinatal complications major congenital anomaly multiple birth
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
424 participants (actual)

Study arms

  • Placebo comparator
    Water

    Newborn infants with ID numbers ending in odd numbers offered 2ml distilled water by syringe once in the side of the infant's mouth 2 minutes before heel stick.

    Other: Water

  • Active comparator
    Sucrose

    Newborn infants with ID numbers ending in even numbers offered 2 ml 25% sucrose in distilled water by syringe once in the side of the infant's mouth 2 minutes before heel stick.

    Other: Sucrose

Interventions

  • OtherWater

    2 ml distilled water by syringe one time in the newborn's mouth 2 minutes before heel stick

  • OtherSucrose

    2 ml 25% sucrose in distilled water by syringe one time in the newborn's mouth 2 minutes before heel stick

06

What researchers measure

Primary outcomes

  1. Infant behavior (emotion regulation)

    Infant behavior observed included activity level, negative emotionality, alertness and soothability.

    Time frame: up to 5 days old

07

Study locations

1 site
  • Peking University First Hospital
    Beijing, 100034, China
08

References and documents

Publications

  • Lumeng JC, Li X, He Y, Gearhardt A, Sturza J, Kaciroti NA, Li M, Asta K, Lozoff B. Greater analgesic effects of sucrose in the neonate predict greater weight gain to age 18 months. Appetite. 2020 Mar 1;146:104508. doi: 10.1016/j.appet.2019.104508. Epub 2019 Nov 4. PubMed 31698014 ↗

Individual participant data

Plan to share: Yes — On request after main findings are published.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 5, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02728141
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Responsible party
Sponsor
First posted
Apr 5, 2016
Start date
Nov 2009
Primary completion
Jun 2014
Completion
Jun 2014
Last update
Apr 5, 2016

Study contacts

Betsy Lozoff, MD
principal investigator · University of Michigan

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion